Berdazimer sodium

N/A

Report date: 2025/07/16 17:21:29
NMEFirst In Class

Base Information

Drug NameBerdazimer sodium
Drug Alias NameBerdazimer gel 10.3%Berdazimer凝胶（10.3%）KINSOLUSTMZelsuvmiZELSUVMI +[15] 
ClassificationSmall molecules
Mechanisms of ActionAndrogen Receptor antagonistsAngiogenesis inducersCell death stimulants +[8] 
TargetsAndrogen ReceptorInterleukin-13Interleukin-4 +[5] 
Therapy Area/IndicationsPsoriasisAcne VulgarisDermatitis, Atopic +[6] 
Global Approved IndicationsMolluscum Contagiosum
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/01/05
Country/TerritoryPanamaUnited StatesHonduras +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Carolina At Chapel Hill
China Registration ClassN/A

Develop Information

Active CompaniesLnhc Inc
Inactive CompaniesNovan Inc
Active IndicationsMolluscum Contagiosum
Inactive IndicationsPsoriasisAcne VulgarisDermatitis, Atopic +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG